Patrick Darb-Esfahani

Learn More
BACKGROUND & AIMS This aim was to determine whether endoscopic implantation of a biocompatible nonresorbable copolymer (Enteryx; Boston Scientific Corp, Natick, MA) is a more effective therapy for gastroesophageal reflux disease (GERD) than a sham procedure. METHODS In a randomized, single-blind, prospective, multicenter clinical trial, 64 patients with(More)
  • 1